STATEMENT: Patients For Affordable Drugs’ Responds To Boehringer Ingelheim’s Oral Arguments In Corporation’s Lawsuit Against Medicare Negotiation
Oral arguments were presented today in the case brought by Boehringer Ingelheim Pharmaceuticals challenging Medicare’s authority to negotiate lower drug prices for patients.